News
This drug led to 50% more weight loss than Wegovy in head-to-head study
While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors find concerning. In trials of Wegovy, up to 40% of weight loss was from a decrease in lean or fat-free mass, rather than excess fat. In addition, quitting the drugs can mean adding back the pounds.
Zepbound Beats Wegovy for Weight Loss in First Head-To-Head Trial of Blockbuster Drugs
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical trial participants who took tirzepatide,
Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.
4hon MSN
Meghan Trainor and her husband, Daryl Sabara, opened up about using Mounjaro — combined with a strict diet and exercise — for ...
Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.
GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...
Ever since the pharmaceutical company Novo Nordisk realized that GLP-1 drugs were useful for more than diabetes, doctors and ...
If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...
Bone broth has been having a moment. An increasing number of folks are including the ingredient as part of their diet, many ...
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...
3h
The pop star was performing the 2014 hit during iHeartRadio’s KIIS-FM Wango Tango Saturday when she made the surprising ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback